Low bioavailability of rectally administered thalidomide.
Eriksson
T
T
Malmö University Hospital (MUH), Sweden. tommy.eriksson@apoteket.se
Wallin
R
R
Höglund
P
P
Roth
B
B
Qi
Z
Z
Ostraat
O
O
Björkman
S
S
D000285:Administration, Rectal; D000328:Adult; D000704:Analysis of Variance; D019540:Area Under Curve; D001682:Biological Availability; D018592:Cross-Over Studies; D005782:Gels; D006801:Humans; D007166:Immunosuppressive Agents / Q000097:blood* / Q000493:pharmacokinetics; D008297:Male; D008875:Middle Aged; D013488:Suppositories; D013792:Thalidomide / Q000097:blood* / Q000493:pharmacokinetics
D005782:Gels; D007166:Immunosuppressive Agents; D013488:Suppositories; D013792:Thalidomide